2781 - 2790 of 6310 Results
Title
Year
-
OPENTitle: Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorderJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1591End Page: 1599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10728-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10728-x.pdfCitation Count: 32
-
OPENTitle: Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort studyJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 46Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-024-07738-8Best OA location URL: https://doi.org/10.1007/s10072-024-07738-8Citation Count: 0
- Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD2024OPENTitle: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PDJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693Best OA location URL: https://doi.org/10.3389/fdgth.2024.1435693Citation Count: 2
-
OPENTitle: Large-scale biophysically detailed model of somatosensory thalamocortical circuits in NetPyNEJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fninf.2022.884245Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2022.884245/pdfCitation Count: 21
-
OPENTitle: Olfactory Dysfunction and Long-Term Trajectories of Sleep Disorders among early Parkinson’s Disease: Findings from a Longitudinal CohortJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol:Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000539330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11797938Citation Count: 1
-
OPENTitle: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-017-0276-4Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0276-4Citation Count: 119
-
OPENTitle: Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 85Issue #: 15Start Page: 1283End Page: 1292Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000002016Best OA location URL: https://n.neurology.org/content/neurology/85/15/1283.full.pdfCitation Count: 27
-
OPENTitle: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549Best OA location URL: https://doi.org/10.3389/fnmol.2024.1431549Citation Count: 1
- Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease2023OPENTitle: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105822End Page: 105822Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10853986/pdf/nihms-1931898.pdfCitation Count: 3
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 2